These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12890622)

  • 1. Antigenic sites of coxsackie A9 virus inducing neutralizing monoclonal antibodies protective in mice.
    Buttinelli G; Donati V; Ruggeri FM; Joki-Korpela P; Hyypia T; Fiore L
    Virology; 2003 Jul; 312(1):74-83. PubMed ID: 12890622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poliovirus Sabin type 1 neutralization epitopes recognized by immunoglobulin A monoclonal antibodies.
    Fiore L; Ridolfi B; Genovese D; Buttinelli G; Lucioli S; Lahm A; Ruggeri FM
    J Virol; 1997 Sep; 71(9):6905-12. PubMed ID: 9261417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of neutralization sites on the circulating variant of swine vesicular disease virus (SVDV): a new site is shared by SVDV and the related coxsackie B5 virus.
    Borrego B; Carra E; García-Ranea JA; Brocchi E
    J Gen Virol; 2002 Jan; 83(Pt 1):35-44. PubMed ID: 11752698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of group I porcine enteroviruses by monoclonal antibodies in cell culture.
    Dauber M
    Vet Microbiol; 1999 Jun; 67(1):1-12. PubMed ID: 10392772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the location of antigenic sites of swine vesicular disease virus with neutralization-resistant mutants.
    Kanno T; Inoue T; Wang Y; Sarai A; Yamaguchi S
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3099-106. PubMed ID: 8847515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformation of the VP2 protein of bluetongue virus (BTV) determines the involvement in virus neutralization of highly conserved epitopes within the BTV serogroup.
    White JR; Eaton BT
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1325-32. PubMed ID: 1693664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of neutralizing epitopes on a European strain of swine vesicular disease virus.
    Nijhar SK; Mackay DK; Brocchi E; Ferris NP; Kitching RP; Knowles NJ
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():277-282. PubMed ID: 10073685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The isolation and characteristics of monoclonal antibodies to the structural proteins of Coxsackie B5 virus].
    Boss A; Piirsoo A
    Vopr Virusol; 1994; 39(2):80-2. PubMed ID: 8017060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus.
    Crowther JR; Rowe CA; Butcher R
    Epidemiol Infect; 1993 Oct; 111(2):391-406. PubMed ID: 7691630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
    Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of four distinct neutralizing epitopes on bluetongue virus serotype 10 using neutralizing monoclonal antibodies and neutralization-escape variants.
    Heidner HW; Rossitto PV; MacLachlan NJ
    Virology; 1990 Jun; 176(2):658-61. PubMed ID: 1693250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic features of foot-and-mouth disease virus serotype Asia1 as revealed by monoclonal antibodies and neutralization-escape mutants.
    Sanyal A; Venkataramanan R; Pattnaik B
    Virus Res; 1997 Aug; 50(2):107-17. PubMed ID: 9282776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of antigenic sites of foot-and-mouth disease virus serotype Asia 1 and relationships with sites described in other serotypes.
    Grazioli S; Fallacara F; Brocchi E
    J Gen Virol; 2013 Mar; 94(Pt 3):559-569. PubMed ID: 23197575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of linear epitopes on the capsid proteins of swine vesicular disease virus using monoclonal antibodies.
    Borrego B; García-Ranea JA; Douglas A; Brocchi E
    J Gen Virol; 2002 Jun; 83(Pt 6):1387-1395. PubMed ID: 12029154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclass restriction of human enterovirus antibodies.
    Torfason EG; Reimer CB; Keyserling HL
    J Clin Microbiol; 1987 Aug; 25(8):1376-9. PubMed ID: 3040799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of monoclonal antibodies raised against a synthetic peptide capable of inducing a neutralizing response to human rhinovirus type 2.
    Barnett PV; Rowlands DJ; Parry NR
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1295-302. PubMed ID: 8393073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic neutralization of rubella virus by monoclonal antibodies to viral haemagglutinin.
    Gerna G; Revello MG; Dovis M; Petruzzelli E; Achilli G; Percivalle E; Torsellini M
    J Gen Virol; 1987 Jul; 68 ( Pt 7)():2007-12. PubMed ID: 2439653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies.
    Czerny CP; Mahnel H
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2341-52. PubMed ID: 1700065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against different epitopes of a 40 Kd capsid protein of infectious bursal disease viruses.
    Lee LH
    Proc Natl Sci Counc Repub China B; 1990 Apr; 14(2):75-84. PubMed ID: 1701058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.
    Gauntt CJ; Arizpe HM; Higdon AL; Wood HJ; Bowers DF; Rozek MM; Crawley R
    J Immunol; 1995 Mar; 154(6):2983-95. PubMed ID: 7533190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.